Drug-related problems and medication reviews among old people with dementia
Tóm tắt
Drug-related problems, including medication errors and adverse drug events, are common among old people. Due to, for example, greater susceptibility to side effects, people with dementia are even more at risk of drug-related problems. The objectives of this study were to assess the occurrence and character of drug-related problems found among old people with dementia or cognitive impairment. Data from a randomized controlled clinical trial exploring the effects of a pharmacist intervention as part of a hospital ward team in patients 65 years and older with dementia or cognitive impairment were used. The study was conducted between 2012 and 2014 in the orthopedic and medicine wards in two hospitals located in Northern Sweden. Drug-related problems identified in this patient group were classified and described, and associations with different factors were investigated. Clinical pharmacists identified at least one DRP in 66% (140/212) of participants in the intervention group, for a total of 310 DRPs. Ineffective drug/inappropriate drug and unnecessary drug therapy were the most common drug-related problems. Discontinuation of drug therapy was the most common action carried out. Drug-related problems were more common among people prescribed a larger number of drugs and among people with an earlier stroke. Drug-related problems are common among people with dementia and cognitive impairment. Comprehensive medication reviews conducted by clinical pharmacists as part of a health care team might be important to prevent, identify and solve these problems.
Tài liệu tham khảo
Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Intern Med J. 2001;31:199–205.
Gustafsson M, Sjölander M, Pfister B, Jonsson J, Schneede J, Lövheim H. Drug-related hospital admissions among old people with dementia. Eur J Clin Pharmacol. 2016;72:1143–53.
Turnheim K. Drug therapy in the elderly. Exp Gerontol. 2004;39:1731–8.
Moore A, O’Keeffe S. Drug- Induced Cognitive Impairment in the Elderly. Drugs Aging. 1999;15:15–28.
Krista LL, Nathan H, Goran E, Van Robert R, Kenton R, Claudio AN. Central Serotonergic Activity is Related to the Aggressive Behaviors of Alzheimer's Disease. Neuropsychopharmacology. 2002;27:646.
Mehta D, Short J, Hilmer S, Nicolazzo J. Drug Access to the Central Nervous System in Alzheimer’s Disease: Preclinical and Clinical Insights. Pharm Res. 2015;32:819–39.
Hayes TL, Larimer N, Adami A, Kaye JA. Medication Adherence in Healthy Elders. J Aging Health. 2009;21:567–80.
ESCP. European Society of Clinical Pharmacy. http://www.escpweb.org. Accessed 14 Jan 2016.
Scullin C, Scott MG, Hogg A, McElnay JC. An innovative approach to integrated medicines management. J Eval Clin Pract. 2007;13:781–8.
PCNE. Pharmaceutical Care Network Europe. Statement on medication review 2011–2012. http://www.pcne.org. Accessed 23 Nov 2015.
Graabaek T, Kjeldsen LJ. Medication reviews by clinical pharmacists at hospitals lead to improved patient outcomes: a systematic review. Basic Clin Pharmacol Toxicol. 2013;112:359–73.
Chisholm-Burns MA, Kim Lee J, Spivey CA, et al. US pharmacists' effect as team members on patient care: systematic review and meta-analyses. Med Care. 2010;48:923–33.
Gustafsson M, Sjölander M, Pfister B, Jonsson J, Schneede J, Lövheim H. Pharmacist participation in hospital ward teams and hospital readmission rates among people with dementia: a randomized controlled trial. Eur J Clin Pharmacol. 2017;73:827–35.
Cipolle R, Strand L, Morely P. Pharmaceutical Care Practice. New York: The McGraw-Hill Companies inc; 1998.
The National Board of Health and Welfare. Indikatorer för god läkemedelsterapi hos äldre. In: Eng. Indicators for evaluating the quality of older people's drug therapy. 2010. http://www.socialstyrelsen.se/publikationer2010/2010-6-29. Accessed 14 Dec 2015.
Blix H, Viktil K, Moger T, Reikvam Å. Characteristics of drug- related problems discussed by hospital pharmacists in multidisciplinary teams. Pharm World Sci. 2006;28:152–8.
Gillespie U, Alassaad A, Henrohn D, et al. A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older: a randomized controlled trial. Arch Intern Med. 2009;169:894–900.
Bishop MA, Cohen BA, Billings LK, Thomas EV. Reducing errors through discharge medication reconciliation by pharmacy services. Am J Health Syst Pharm. 2015;72:120–6.
Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57:6–14.
Khanal A, Peterson GM, Castelino RL, Jose MD. Potentially inappropriate prescribing of renally cleared drugs in elderly patients in community and aged care settings. Drugs Aging. 2015;32:391–400.
Sönnerstam E, Sjölander M, Gustafsson M. Inappropriate Prescription and Renal Function Among Older Patients with Cognitive Impairment. Drugs & Aging. 2016;33:889–99.
Semla TP, Beizer JL, Higbee MD. Geriatric Dosage Handbook. 16th ed. Ohio: Lexicomp; 2011.
Gosch M, Wortz M, Nicholas JA, Doshi HK, Kammerlander C, Lechleitner M. Inappropriate prescribing as a predictor for long-term mortality after hip fracture. Gerontology. 2014;60:114–22.
Gustafsson M, Sandman PO, Karlsson S, Gustafson Y, Lovheim H. Association between behavioral and psychological symptoms and psychotropic drug use among old people with cognitive impairment living in geriatric care settings. Int Psychogeriatr. 2013;25:1415–23.
Langman MJ, Weil J, Wainwright P, et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet. 1994;343:1075–8.
Bleumink GS, Feenstra J, Sturkenboom MC, Stricker BH. Nonsteroidal anti-inflammatory drugs and heart failure. Drugs. 2003;63:525–34.
Juurlink DN, Mamdani M, Kopp A, Laupacis A, Redelmeier DA. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA. 2003;289:1652–8.
Kara M, Hasinoff B, McKay D, Campbell N. Clinical and chemical interactions between iron preparations and ciprofloxacin. Br J Clin Pharmacol. 1991;31:257–61.
Ogura Y, Gonsho A, Cyong J-C, Orimo H. Clinical trial of risedronate in Japanese volunteers: a study on the effects of timing of dosing on absorption. J Bone Miner Metab. 2004;22:120–6.
Campbell NR, Hasinoff BB, Stalts H, Rao B, Wong NC. Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism. Ann Intern Med. 1992;117:1010.
Alassaad A, Bertilsson M, Gillespie U, Sundstrom J, Hammarlund-Udenaes M, Melhus H. The effects of pharmacist intervention on emergency department visits in patients 80 years and older: subgroup analyses by number of prescribed drugs and appropriate prescribing. PLoS One. 2014;9:1–7.
Salvi F, Marchetti A, D'Angelo F, Boemi M, Lattanzio F, Cherubini A. Adverse drug events as a cause of hospitalization in older adults. Drug Saf. 2012;35:29–45.